Home / Brands / Health Solutions Pharmacy Center Inc
Health Solutions Pharmacy Center Inc Recalls
25 recalls on record · April 17, 2019 to April 17, 2019 · Drugs
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.64MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 17.44-0.58MG-5.8MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 15-0.25MG-6MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd.
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-20 MCG/ML* INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blv
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 9-1 MG-10 MCG/ML* INJECTABLE, 18 ml, Professional Compounding Pharmacy, 996 NW Circle Blvd.
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 22.5-0.8MG-8.3MCG/ML INJECTABLE, 5 ml, Professional Compounding Pharmacy, 996 NW Circle Blv
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 17.64-0.58MG-5.88MCG/ML* INJECTABLE, 9 ml, Professional Compounding Pharmacy, 996 NW Circle
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 16.6-0.55 MG-11.1 MCG/ML* INJECTABLE, 10 ml, Professional Compounding Pharmacy, 996 NW Circ
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 15-0.5MG-10MCG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 30-2 MG-30 MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle Blvd
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE 30-0.5 MG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corval
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE 15-0.5MGMG/ML INJECTABLE, 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corva
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PGE1-LIDOCAINE 40 MCG-1% /ML* INJECTABLE, (a) 10 ml (b) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 30-1.6 MG-16 MCG/ML* INJECTABLE, (a) 5ml, (b) 10ml, Professional Compounding Pharmacy, 996
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 23-0.96MG-19.2MCG/ML INJECTABLE, (a) 5ml, (b) 6.5ml, Professional Compounding Pharmacy, 996
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 17.16-0.57MG-19.45MCG/ML* INJECTABLE, 5ml, Professional Compounding Pharmacy, 996 NW Circle
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 12-1MG-10MCG/ML INJECTABLE, (a) 10ml, (b) 9ml, Professional Compounding Pharmacy, 996 NW Ci
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compoundi
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 9
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PGE1 40 MCG/ML* INJECTABLE, (2) 5ml (b) 10ml, (c) 6ml (d) 9ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #1
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls PAPAVERINE-PHENTOLAMINE-PGE1 22-0.8 MG-8 MCG/ML* INJECTABLE, (a) 5ml (b) 10ml, (c) 6ml, penile injection, Professional C
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL* INJECTABLE, (a) 10ml (b) 9ml injectable, Professional Compounding Pharmacy
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls ACETYL-L-CYSTEINE 10% P.F. OPHTH SOLUTION, 10ml, eye drops, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls DEXAMETHASONE (NAPO4) 0.1% OPHTH* PRES-FREE SOLUTION, 10ml, Eye Drops, Professional Compounding Pharmacy, 996 NW Circle
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
April 17, 2019DrugsFDA
Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy recalls SODIUM CHLORIDE PRES-FREE 5% OPHTH STERILE* SOLUTION. 20ml eye drops, Professional Compounding Pharmacy, 996 NW Circle B
Hazard: Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.